Altris AI launches advanced glaucoma Optic Disc Analysis module

News
Article

Key parameters captured by the module include disc area, cup area, cup volume, minimal cup depth, maximum cup depth, cup/disc area ratio, rim absence angle, and disc-damage likelihood scale.

AI graphic of motherboard Image credit: AdobeStock/Kaikoro

Image credit: AdobeStock/Kaikoro

Altris AI has announced the launch of an advanced glaucoma Optic Disc Analysis module intended to aid in the early detection of the disease. The new artificial intelligence (AI) module builds upon an earlier innovation that utilizes Ganglion Cell Complex (GCC) Asymmetry Analysis that will enhance improvements from the Altris AI macula module, according to a news release.

“The launch of our Advanced Optic Disc Analysis module marks a pivotal step forward in glaucoma care,” said Maria Znamenska, MD, PhD, chief medical officer at Altris AI, in the release. “By combining the gold standard of optic disc evaluation with AI-powered precision, we’re equipping eye care professionals with the tools to make more accurate and timely diagnosis of this vision-threatening disorder. This innovation not only reduces false positive referrals but also enhances early detection and treatment planning—ensuring better outcomes for patients and optimizing healthcare resources. Together with GCC asymmetry analysis, our platform empowers clinicians to elevate the standard of glaucoma care, offering hope to millions at risk of vision loss.”

Key parameters captured by the module include disc area, cup area, cup volume, minimal cup depth, maximum cup depth, cup/disc area ratio, rim absence angle, and disc-damage likelihood scale. Optic disc parameters are evaluated by the module using optical coherence tomography (OCT), which allows for personalized assessments by accounting for individual disc sizes and angle of rim absence. Additionally, the platform assigns a severity score for optic disc damage on a scale of 1 to 10.

The Altris Glaucoma Module is compatible with 3D OCT optic disc, horizontal wide, and vertical-wide scans, as well as OCT optic disc raster scans. Cross-evaluation is available across these OCT systems, which allows eye care providers to analyze both macula and optic disc pathology, even if data originates from multiple OCT devices.

Altris launched its AI-powered Advanced Optic Disc Analysis module in February 2025.

Reference
  1. Altris AI launches advanced Optic Disc Analysis for glaucoma. News release. Altris AI. Accessed March 3, 2025. https://www.altris.ai/article/altris-ai-launches-advanced-optic-disc-analysis-for-glaucoma-complementing-gcc-asymmetry-analysis/

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
At CIME 2025, Selina McGee, OD, FAAO, says some patients underestimate oculoplastic care. She stands in front of a sign that says Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.